- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/03 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
Patent holdings for IPC class A61K 38/03
Total number of patents in this class: 552
10-year publication summary
|
26
|
46
|
42
|
54
|
42
|
30
|
56
|
33
|
25
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19517 |
13 |
| Thetis Pharmaceuticals LLC | 23 |
7 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2617 |
6 |
| Xigen SA | 19 |
6 |
| Realta Holdings, LLC | 25 |
6 |
| The Board of Trustees of the Leland Stanford Junior University | 6246 |
5 |
| Dana-Farber Cancer Institute, Inc. | 2535 |
5 |
| Universite de Strasbourg | 663 |
5 |
| University of Washington | 2252 |
5 |
| Xigen Inflammation Ltd. | 31 |
5 |
| Limited Liability Company "mitotechnology" | 9 |
5 |
| Gel4Med Inc. | 23 |
5 |
| Wisconsin Alumni Research Foundation | 3820 |
4 |
| The Board of Trustees of the University of Illinois | 2666 |
4 |
| Ohio State Innovation Foundation | 1978 |
4 |
| Regeneron Pharmaceuticals, Inc. | 3986 |
4 |
| The University of Melbourne | 523 |
4 |
| The Board of Regents of the University of Texas System | 2132 |
4 |
| Centre National de La Recherche Scientifique | 10102 |
3 |
| National Institute of Advanced Industrial Science and Technology | 3736 |
3 |
| Other owners | 449 |